China SXT Pharmaceuticals, Inc.
Market Cap
$1.54M
P/E Ratio
-0.03
EPS
$-57.15
Dividend Yield
0.00%
52-Week Range
$1.76 — $1047.00
Volume
15.66K
Avg Volume
298.20K
Beta
1.74
P/E (TTM)
-0.03
Forward P/E
—
PEG Ratio
0.00
P/S (TTM)
1.29
P/B (TTM)
0.24
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.18%
ROA (TTM)
-0.11%
ROIC
—
Gross Margin
0.23%
Operating Margin
-1.78%
Net Margin
—
Debt/Equity
0.06
Current Ratio
4.37
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.13%
EPS Growth (5Y)
+0.17%
Sales Growth (3Y)
-0.12%
Sales Growth (5Y)
-0.18%
EPS Est (This Year)
—
EPS Est (Next Year)
—
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$8.67
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
853.51K
Float
853.51K
Free Float %
100.00%
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
CN
Exchange
NASDAQ
IPO Date
2019-01-04
Employees
75
CEO
Feng Zhou
Index Membership
—
Website
https://www.sxtchina.com
China SXT Pharmaceuticals, Inc. (SXTC) is a healthcare company in the drug manufacturers - specialty & generic industry listed on the NASDAQ. With a market capitalization of $1.54M, a P/E ratio of -0.03, SXTC is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare SXTC against other stocks using dozens of fundamental and technical filters.
China SXT Pharmaceuticals, Inc. (SXTC) has a trailing twelve-month (TTM) P/E ratio of -0.03. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, China SXT Pharmaceuticals, Inc. (SXTC) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
China SXT Pharmaceuticals, Inc. (SXTC) has a market capitalization of $1.54 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.